These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17618725)

  • 41. Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin.
    Bains OS; Grigliatti TA; Reid RE; Riggs KW
    J Pharmacol Exp Ther; 2010 Dec; 335(3):533-45. PubMed ID: 20837989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioequivalence studies of tibolone in premenopausal women and effects on expression of the tibolone-metabolizing enzyme AKR1C (aldo-keto reductase) family caused by estradiol.
    Kang KW; Kim YG
    J Clin Pharmacol; 2008 Dec; 48(12):1430-7. PubMed ID: 18832293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aldo-keto reductase 1C subfamily genes in skin are UV-inducible: possible role in keratinocytes survival.
    Marín YE; Seiberg M; Lin CB
    Exp Dermatol; 2009 Jul; 18(7):611-8. PubMed ID: 19320734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification and characterization of carbonyl reductases from bovine liver cytosol and microsome. The cytosolic enzyme has a novel 3 alpha/17 beta-hydroxysteroid dehydrogenase activity.
    Terada T; Niwase N; Koyama I; Imamura M; Shinagawa K; Toya H; Mizoguchi T
    Int J Biochem; 1993 Sep; 25(9):1233-9. PubMed ID: 8224367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human cytosolic hydroxysteroid dehydrogenases of the aldo-ketoreductase superfamily catalyze reduction of conjugated steroids: implications for phase I and phase II steroid hormone metabolism.
    Jin Y; Duan L; Lee SH; Kloosterboer HJ; Blair IA; Penning TM
    J Biol Chem; 2009 Apr; 284(15):10013-22. PubMed ID: 19218247
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitors of human 20α-hydroxysteroid dehydrogenase (AKR1C1).
    El-Kabbani O; Dhagat U; Hara A
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):105-11. PubMed ID: 21050889
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily.
    Hoffmann F; Maser E
    Drug Metab Rev; 2007; 39(1):87-144. PubMed ID: 17364882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reductive metabolism of nabumetone by human liver microsomal and cytosolic fractions: exploratory prediction using inhibitors and substrates as marker probes.
    Matsumoto K; Hasegawa T; Koyanagi J; Takahashi T; Akimoto M; Sugibayashi K
    Eur J Drug Metab Pharmacokinet; 2015 Jun; 40(2):127-35. PubMed ID: 24659525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases.
    Malátková P; Sokolová S; Chocholoušová Havlíková L; Wsól V
    Biochem Pharmacol; 2016 Jun; 109():83-90. PubMed ID: 27055738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular docking simulations of steroid substrates into human cytosolic hydroxysteroid dehydrogenases (AKR1C1 and AKR1C2): insights into positional and stereochemical preferences.
    Jin Y; Penning TM
    Steroids; 2006 May; 71(5):380-91. PubMed ID: 16455123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of neoplastic transformation by ectopic expression of human aldo-keto reductase 1C isoforms in NIH3T3 cells.
    Chien CW; Ho IC; Lee TC
    Carcinogenesis; 2009 Oct; 30(10):1813-20. PubMed ID: 19696165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of rat hepatocytes immobilized in agarose gel threads for biosynthesis of metabolites of potential cytostatics.
    Trejtnar F; Skálová L; Szotáková B; Wsól V
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):432-5. PubMed ID: 10445411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ruthenium complexes as inhibitors of the aldo-keto reductases AKR1C1-1C3.
    Traven K; Sinreih M; Stojan J; Seršen S; Kljun J; Bezenšek J; Stanovnik B; Turel I; Rižner TL
    Chem Biol Interact; 2015 Jun; 234():349-59. PubMed ID: 25446855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor.
    Ghosal A; Yuan Y; Tong W; Su AD; Gu C; Chowdhury SK; Kishnani NS; Alton KB
    Drug Metab Dispos; 2011 Mar; 39(3):510-21. PubMed ID: 21123164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluorogenic metabolic probes for direct activity readout of redox enzymes: Selective measurement of human AKR1C2 in living cells.
    Yee DJ; Balsanek V; Bauman DR; Penning TM; Sames D
    Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13304-9. PubMed ID: 16938874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of bovine liver cytosolic 3 alpha-hydroxysteroid dehydrogenase and its aldo-keto reductase activity.
    Nanjo H; Terada T; Umemura T; Nishinaka T; Mizoguchi T; Nishihara T
    Int J Biochem; 1992 May; 24(5):815-20. PubMed ID: 1592159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of cytochrome P4501A in biotransformation of the potential anticancer drug oracin.
    Szotáková B; Wsól V; Skálová L; Kvasnicková E
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):428-31. PubMed ID: 10445410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro metabolism of fenofibric acid by carbonyl reducing enzymes.
    Malátková P; Kanavi M; Nobilis M; Wsól V
    Chem Biol Interact; 2016 Oct; 258():153-8. PubMed ID: 27599626
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of experimental kidney disease on the functional expression of hepatic reductases.
    Alshogran OY; Naud J; Ocque AJ; Leblond FA; Pichette V; Nolin TD
    Drug Metab Dispos; 2015 Jan; 43(1):100-6. PubMed ID: 25332430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
    Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
    Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.